Att 2b_Summary of Public Comments 092309

Attachment 2b

Summary of Public Comments and CDC Response

Assessing Problem Areas in Referrals for Chronic Hematologic Malignancies and Developing Interventions to Address Them

Federal Register Notice: A 60-day Notice was published in the Federal Register on April 13, 2009, Vol. 74, No. 69, pp. 16873-16874.

CDC received 2 public comments in response to the Federal Register Notice

1. 4sightresearchpartners

This morning, I read in the Federal Register (http://www.federalregister.gov/inspection.aspx#special) the proposal for Referrals for Chronic Hematologic Malignancies, 2009-08337. 

How do I tract the progress of this request?  I'd like to see the results, and preferably, know when the results are posted.  I'm a research analyst of life science companies, including hem/onc biotechs.

I track some Citizen Petitions through regulations.gov, but I don't believe that will work for this.  I appreciate any help you can provide.

Regards,

Michael

Michael Higgins

Managing Partner

4sight Research Partners, LLP

66 Woodport Rd, Suite 5

Sparta, NJ 07871

www.4sightresearchpartners.com

973-729-2640, office

530-400-9402, mobile

HigginsonIM, AIM

CDC Response

“Thank you for your inquiry regarding the Federal Register notice 09-0410 concerning CDC’s planned project on Referrals for Chronic Hematologic Malignancies. We are happy to send the results of this study to you directly when they are available.”

2. The American Society of Hematology

The American Society of Hematology (ASH) requested additional information about the proposed project, including an outline of study methodology and draft information collection instruments, which were provided for ASH’s review. The American Society of Hematology also submitted a letter of support for the project which included recommendations pertaining to study design (see letter, attached). CDC’s reply to the letter is included below.

CDC Response

CDC considered ASH’s recommendations and provided the following reply:

“Thank you for your inquiry and follow-up related to Dr. Solberg’s letter, on behalf of the American Society of Hematology, regarding CDC’s planned study on Referrals for Chronic Hematologic Malignancies (Federal Register Vol. 74, No. 69, pp. 16873-16874). The letter recommends that the study be conducted in a broader geographic region than Texas and Massachusetts. We agree that more national representation is desirable. The funds for this formative research study, however, do not allow such an endeavor at this time. Our plan is to use the information we collect in this study to develop and test an intervention that shortens the time between diagnosis and seeing a specialist.

As the study progresses, we are most happy to share results with you and discuss potential areas of collaboration in future research. Again, thank you for your encouragement.”

 

5